Amdocs Limited (NASDAQ:DOX – Free Report) – Investment analysts at Zacks Research reduced their Q3 2025 earnings estimates for shares of Amdocs in a note issued to investors on Tuesday, February 25th. Zacks Research analyst R. Department now expects that the technology company will post earnings per share of $1.55 for the quarter, down from their previous forecast of $1.58. The consensus estimate for Amdocs’ current full-year earnings is $6.21 per share. Zacks Research also issued estimates for Amdocs’ Q4 2025 earnings at $1.62 EPS, FY2025 earnings at $6.16 EPS, Q3 2026 earnings at $1.69 EPS, Q4 2026 earnings at $1.74 EPS, FY2026 earnings at $6.69 EPS and FY2027 earnings at $7.11 EPS.
A number of other equities research analysts also recently issued reports on the company. Barclays decreased their price objective on Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research report on Thursday, November 14th. Oppenheimer raised their price target on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Finally, StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Amdocs currently has a consensus rating of “Moderate Buy” and an average price target of $101.20.
Amdocs Stock Down 0.2 %
Shares of DOX opened at $87.74 on Friday. Amdocs has a 1 year low of $74.41 and a 1 year high of $94.04. The stock has a market capitalization of $9.91 billion, a price-to-earnings ratio of 20.36, a price-to-earnings-growth ratio of 1.47 and a beta of 0.71. The business’s 50 day simple moving average is $86.21 and its 200-day simple moving average is $86.75. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20.
Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the business. Creative Planning boosted its position in shares of Amdocs by 37.3% in the 3rd quarter. Creative Planning now owns 15,111 shares of the technology company’s stock worth $1,322,000 after purchasing an additional 4,104 shares in the last quarter. Private Advisor Group LLC raised its holdings in shares of Amdocs by 3.2% during the third quarter. Private Advisor Group LLC now owns 5,626 shares of the technology company’s stock worth $492,000 after purchasing an additional 175 shares during the last quarter. International Assets Investment Management LLC acquired a new position in Amdocs during the third quarter valued at $8,950,000. Wealth Enhancement Advisory Services LLC boosted its holdings in Amdocs by 3.9% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 65,430 shares of the technology company’s stock valued at $5,724,000 after purchasing an additional 2,435 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale grew its position in Amdocs by 4.9% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 107,432 shares of the technology company’s stock worth $9,192,000 after purchasing an additional 5,000 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.
Amdocs Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Sunday, April 20th. Stockholders of record on Monday, March 31st will be given a dividend of $0.527 per share. This is an increase from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.40%. Amdocs’s dividend payout ratio is presently 48.72%.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles
- Five stocks we like better than Amdocs
- Stock Analyst Ratings and Canadian Analyst Ratings
- 3 Stocks Breaking Out with More Growth Potential Ahead
- Canadian Penny Stocks: Can They Make You Rich?
- Not Just China: 3 European Stocks Gaining Investor Interest
- How to Capture the Benefits of Dividend Increases
- 3 Mid-Caps Worth Watching Closely in MarchÂ
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.